Exelixis
EXEL
#1743
Rank
S$14.95 B
Marketcap
S$55.80
Share price
1.40%
Change (1 day)
12.45%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Number of shares outstanding for Exelixis (EXEL)

Number of shares outstanding as of April 2026 : 266,458,000

According to Exelixis's latest financial reports and stock price the company's current number of shares outstanding is 266,458,000. At the end of 2025 the company had 266,458,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Exelixis from 2000 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.26 B-6.71%
20240.28 B-7.41%
20230.30 B-4.57%
20220.32 B1.79%
20210.31 B2.19%
20200.31 B2.11%
20190.30 B1.65%
20180.29 B1.14%
20170.29 B2.73%
20160.28 B26.69%
20150.22 B16.32%
20140.19 B6.05%
20130.18 B10.83%
20120.16 B28.81%
20110.12 B18.84%
20100.10 B1.24%
20090.10 B1.69%
20080.10 B7.1%
200798.55 M17.07%
200684.17 M5.83%
200579.54 M10.21%
200472.17 M1.66%
200370.99 M25.69%
200256.48 M18.29%
200147.75 M15.96%
200041.17 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Johnson & Johnson
JNJ
2,407,939,000 803.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
5,686,000,000 2,033.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
539,000,000 102.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,425,400,000 810.24%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
2,474,626,766 828.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,036,000,000 664.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,009,500,000 654.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
15,680,178-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
34,618,000-87.01%๐Ÿ‡บ๐Ÿ‡ธ USA